Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ARDMQ OTCMKTS:ARTH OTCMKTS:ENDV OTCMKTS:UMGP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDMQAradigm$0.05$0.05$0.02▼$0.20$764KN/A21,923 shsN/AARTHArch Therapeutics$0.12$0.16▼$1.57$763K4.024,068 shs150 shsENDVEndonovo Therapeutics$0.00-50.0%$0.00$0.00▼$0.00$120K-1.349.25 million shs183.40 million shsUMGPDalton Industries$0.02+4.5%$0.03$0.02▼$0.16$850K0.137,578 shs1,500 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDMQAradigm0.00%0.00%0.00%0.00%0.00%ARTHArch Therapeutics0.00%0.00%0.00%+33.33%-99.82%ENDVEndonovo Therapeutics0.00%-50.00%0.00%0.00%-90.00%UMGPDalton Industries+4.55%-6.88%-13.21%-11.54%-77.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDMQAradigmN/AN/AN/AN/AN/AN/AN/AN/AARTHArch TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AENDVEndonovo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDMQAradigm 0.00N/AN/AN/AARTHArch Therapeutics 0.00N/AN/AN/AENDVEndonovo Therapeutics 0.00N/AN/AN/AUMGPDalton Industries 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDMQAradigmN/AN/AN/AN/AN/AN/AARTHArch Therapeutics$80K0.00N/AN/A($2.43) per share0.00ENDVEndonovo Therapeutics$10K12.07N/AN/A($0.08) per share0.00UMGPDalton Industries$30K28.21N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDMQAradigmN/AN/A0.00∞N/AN/AN/AN/AN/AARTHArch Therapeutics-$6.98MN/A0.00N/AN/A-8,257.70%N/A-730.22%N/AENDVEndonovo Therapeutics-$2.80MN/A0.00∞N/AN/AN/AN/AN/AUMGPDalton Industries-$260K-$0.01N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDMQAradigmN/AN/AN/AN/AN/AARTHArch TherapeuticsN/AN/AN/AN/AN/AENDVEndonovo TherapeuticsN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDMQAradigmN/AN/AN/AARTHArch TherapeuticsN/A0.100.01ENDVEndonovo TherapeuticsN/AN/AN/AUMGPDalton IndustriesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDMQAradigmN/AARTHArch Therapeutics6.91%ENDVEndonovo TherapeuticsN/AUMGPDalton IndustriesN/AInsider OwnershipCompanyInsider OwnershipARDMQAradigm4.50%ARTHArch Therapeutics4.50%ENDVEndonovo Therapeutics5.61%UMGPDalton IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDMQAradigm2315.28 millionN/ANot OptionableARTHArch Therapeutics104.74 million4.53 millionNot OptionableENDVEndonovo Therapeutics11.21 billion1.14 billionNot OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableENDV, UMGP, ARDMQ, and ARTH HeadlinesRecent News About These CompaniesUMGP Universal Media Group Inc. - Seeking AlphaJuly 27, 2025 | seekingalpha.comPatrick Whitesell’s New Investment Firm WTSL Launches A New J.V. With UMGJune 14, 2025 | celebrityaccess.comCUMG & Ex-Endeavor Exec Patrick Whitesell Form Joint Venture to Extend Artists’ IP Beyond MusicJune 14, 2025 | billboard.comBUMG JV with investment firm WTSL focuses on ‘artist-led IP’June 13, 2025 | musically.comMUniversal Music and Hollywood agent Patrick Whitesell launch joint venture.. with backing from SilverlakeJune 12, 2025 | musicbusinessworldwide.comMPatrick Whitesell Starts Joint Venture With Universal Music GroupJune 12, 2025 | msn.comExecs at YouTube Music, WMG, UMG, VEVO, Roc Nation, Recording Academy & More Denounce Anti-Israel Extremism and AntisemitismMay 30, 2025 | msn.comBeastie Boys, UMG settle lawsuits against Chili’s over ‘Sabotage’ adsMay 23, 2025 | msn.comBeastie Boys and UMG Settle Lawsuits With Chili’s Over ‘Sabotage’ Use in AdsMay 22, 2025 | msn.comPENN 2 Welcomes Universal Music Group in Headquarters MoveMay 22, 2025 | globest.comGSalt-N-Pepa sue Universal over ownership of master recordings – UMG says it remains ‘committed to working towards an amicable resolution’May 21, 2025 | musicbusinessworldwide.comMSalt-N-Pepa Sue Universal Music Group Over Music Rights and Album RemovalMay 21, 2025 | thesource.comTUniversal Music Fires Back Against Salt-N-Pepa’s ‘Unreasonable Demands,’ Says It’s ‘Committed to Working Towards an Amicable Resolution’May 21, 2025 | msn.comUMG and Beastie Boys Settle Lawsuits Against Chili’s Over Social Media AdsMay 21, 2025 | billboard.comBUniversal Music Group to Relocate New York Offices to Manhattan’s Penn DistrictMay 21, 2025 | rebusinessonline.comRMatt Ellis named Chief Financial Officer of Universal Music GroupMay 13, 2025 | exchange4media.comEUniversal Music Group N.V.: UNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finanznachrichten.deUNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finance.yahoo.comUniversal Music Group appoints Matt Ellis as new CFOMay 12, 2025 | investing.comUniversal Music Group Names Matt Ellis Chief Financial OfficerMay 12, 2025 | variety.comVENDV, UMGP, ARDMQ, and ARTH Company DescriptionsAradigm OTCMKTS:ARDMQ$0.05 0.00 (0.00%) As of 06/30/2020Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.Arch Therapeutics OTCMKTS:ARTHArch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.Endonovo Therapeutics OTCMKTS:ENDV$0.0001 0.00 (-50.00%) As of 08/22/2025 11:13 AM EasternEndonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.Dalton Industries OTCMKTS:UMGP$0.02 +0.00 (+4.55%) As of 08/22/2025 12:16 PM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access